Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention

David M Leistner1, Jens Klotsche, Lars Pieper

  • 1Department of Medicine III, Cardiology, Goethe-University Frankfurt, Germany.

Clinical Chemistry
|December 14, 2011
PubMed

Insights

Minute elevations in cardiac troponin I (cTnI) predict mortality and major adverse cardiovascular events (MACE) in primary prevention. Sensitive cTnI assays enhance cardiovascular risk assessment beyond traditional factors.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Biomarker Research

Background:

  • Novel sensitive assays detect minute cardiac troponin elevations, linking them to mortality in various populations.
  • The prognostic value of sensitive cardiac troponin I (cTnI) assays for primary prevention risk assessment remains less defined.

Purpose of the Study:

  • To evaluate the incremental value of sensitive cardiac troponin I (cTnI) measurement for cardiovascular risk assessment in primary prevention.

Main Methods:

  • Measured circulating cTnI, NT-proBNP, and hsCRP in 5388 individuals without known cardiovascular disease (DETECT study).
  • Assessed prognostic implications for incident major adverse cardiovascular events (MACE) over 5 years.

Main Results:

  • Circulating cTnI was detectable in 19% of subjects and associated with atherosclerosis risk factors.
  • Increased cTnI showed a graded relationship with all-cause mortality and incident MACE.
  • A single cTnI measurement significantly improved risk prediction, adding prognostic information beyond NT-proBNP and hsCRP.

Conclusions:

  • Minute cTnI increases identify individuals at higher risk for mortality and MACE in primary prevention.
  • Sensitive cTnI assays capture cardiovascular risk not fully addressed by traditional risk factors.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...